News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
PAPADOPOULOS STELIOS
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/14/2023 |
4
| PAPADOPOULOS STELIOS (Director) has filed a Form 4 on Regulus Therapeutics Inc.|
Txns:
| Granted 15,000 options to buy
@ $1.36, valued at
$20.4k
|
|
| 06/02/2023 |
4
| PAPADOPOULOS STELIOS (Director) has filed a Form 4 on EXELIXIS, INC.|
Txns:
| Granted 20,718 shares
@ $0 |
|
| 04/14/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
4
| PAPADOPOULOS STELIOS (Director) has filed a Form 4 on Regulus Therapeutics Inc.|
Txns:
| Granted 90,000 options to buy
@ $0.27, valued at
$24.3k
|
|
| 05/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/01/2021 |
4
| PAPADOPOULOS STELIOS (Director) has filed a Form 4 on Regulus Therapeutics Inc.|
Txns:
| Granted 2,222,222 shares
@ $0.36, valued at
$800k
|
|
| 07/02/2021 |
4
| PAPADOPOULOS STELIOS (Director) has filed a Form 4 on BIOGEN INC.|
Txns:
| Granted 1,275 shares
@ $0 |
|
| 06/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/28/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/07/2020 |
4
| PAPADOPOULOS STELIOS (Director) has filed a Form 4 on Regulus Therapeutics Inc.|
Txns:
| Granted 793,528 shares
@ $0.6301, valued at
$500k
Granted 595,146 warrants
@ $0.7464, valued at
$444.2k
|
|
| 11/27/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/19/2020 |
4
| PAPADOPOULOS STELIOS (Director) has filed a Form 4 on Regulus Therapeutics Inc.|
Txns:
| Granted 23,250 options to buy
@ $0.88, valued at
$20.5k
|
|
| 06/05/2020 |
4
| PAPADOPOULOS STELIOS (Director) has filed a Form 4 on BIOGEN INC.|
Txns:
| Granted 1,470 shares
@ $0 |
|
| 05/22/2020 |
4
| PAPADOPOULOS STELIOS (Director) has filed a Form 4 on EXELIXIS, INC.|
Txns:
| Granted 15,538 shares
@ $0 |
|
| 05/15/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/08/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/04/2020 |
4
| PAPADOPOULOS STELIOS (Director) has filed a Form 4 on Regulus Therapeutics Inc.|
Txns:
| Converted 846,320 shares
@ $0
Converted 84,632 options to buy
@ $0 |
|
| 12/26/2019 |
4
| PAPADOPOULOS STELIOS (Director) has filed a Form 4 on Regulus Therapeutics Inc.|
Txns:
| Granted 84,632 options to buy
@ $6.66, valued at
$563.6k
Granted 846,320 warrants
@ $0.666, valued at
$563.6k
|
|
| 10/15/2019 |
4
| PAPADOPOULOS STELIOS (Director) has filed a Form 4 on Regulus Therapeutics Inc.|
Txns:
| Granted 46,500 options to buy
@ $0.64, valued at
$29.8k
|
|
| 06/20/2019 |
4
| PAPADOPOULOS STELIOS (Director) has filed a Form 4 on BIOGEN INC.|
Txns:
| Granted 1,905 shares
@ $0 |
|
| 05/24/2019 |
4
| PAPADOPOULOS STELIOS (Director) has filed a Form 4 on EXELIXIS, INC.|
Txns:
| Granted 10,317 shares
@ $0
Granted 20,634 options to buy
@ $19.77, valued at
$407.9k
|
|
| 05/08/2019 |
4
| PAPADOPOULOS STELIOS (Director) has filed a Form 4 on Regulus Therapeutics Inc.|
Txns:
| Bought 370,370 shares
@ $1.08, valued at
$400k
Bought 370,370 warrants
@ $1.08, valued at
$400k
|
|
| 02/22/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/02/2019 |
4
| PAPADOPOULOS STELIOS (Director) has filed a Form 4 on Regulus Therapeutics Inc.|
Txns:
| Bought 50,000 shares
@ $1.0914, valued at
$54.6k
|
|
| 12/28/2018 |
4
| PAPADOPOULOS STELIOS (Director) has filed a Form 4 on Regulus Therapeutics Inc.|
Txns:
| Bought 90,000 shares
@ $0.9542, valued at
$85.9k
Bought 26,401 shares
@ $1.0401, valued at
$27.5k
|
|
| 11/21/2018 |
4
| PAPADOPOULOS STELIOS (Director) has filed a Form 4 on Regulus Therapeutics Inc.|
Txns:
| Granted 20,910 shares
@ $0
Disposed/sold 152 options to buy
@ $31.92, valued at
$4.9k
Disposed/sold 1,458 options to buy
@ $111.84, valued at
$163.1k
Disposed/sold 1,458 options to buy
@ $74.64, valued at
$108.8k
Disposed/sold 1,458 options to buy
@ $120.24, valued at
$175.3k
Disposed/sold 3,051 options to buy
@ $74.4, valued at
$227k
Disposed/sold 2,500 options to buy
@ $17.4, valued at
$43.5k
Disposed/sold 6,250 options to buy
@ $8.52, valued at
$53.3k
Disposed/sold 4,583 options to buy
@ $8.76, valued at
$40.1k
|
|
| 11/19/2018 |
4
| PAPADOPOULOS STELIOS (Director) has filed a Form 4 on Regulus Therapeutics Inc.|
Txns:
| Bought 200,000 shares
@ $1.3254, valued at
$265.1k
Bought 300,000 shares
@ $1.3849, valued at
$415.5k
|
|
| 06/14/2018 |
4
| PAPADOPOULOS STELIOS (Director) has filed a Form 4 on BIOGEN INC.|
Txns:
| Granted 1,450 shares
@ $0 |
|
| 06/05/2018 |
4
| PAPADOPOULOS STELIOS (Director) has filed a Form 4 on Regulus Therapeutics Inc.|
Txns:
| Granted 55,000 options to buy
@ $0.73, valued at
$40.2k
|
|
| 05/24/2018 |
4
| PAPADOPOULOS STELIOS (Director) has filed a Form 4 on EXELIXIS, INC.|
Txns:
| Granted 7,937 shares
@ $0
Granted 15,874 options to buy
@ $20.5, valued at
$325.4k
|
|
| 05/21/2018 |
4
| PAPADOPOULOS STELIOS (Director) has filed a Form 4 on Regulus Therapeutics Inc.|
Txns:
| Granted 75,000 options to buy
@ $0.71, valued at
$53.3k
|
|
|
|
|